Development and validation of nomogram models for predicting immune-related adverse events in recurrent and metastatic nasopharyngeal carcinoma patients treated with PD-L1 inhibitors

Development and validation of nomogram models for predicting immune-related adverse events in recurrent and metastatic nasopharyngeal carcinoma patients treated with PD-L1 inhibitors

ObjectiveTo predict the incidence of immune-related Adverse Events (irAEs) in patients with recurrent or metastatic Nasopharyngeal Carcinoma (NPC) treated with Programmed Death-Ligand 1 (PD-L1) inhibitors, this study developed and validated nomogram models incorporating demographic, clinical, and bi...

Full description

Saved in:
Bibliographic Details
Main Authors: Mengyuan Liu, Zheran Liu, Shuangshuang He, Yiyan Pei, Shihong Xu, Junyou Ge, Yan Qing, Youneng Wei, Ye Chen, Ping Ai, Xingchen Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Oncology
Subjects:
NPC
irAEs
PD-L1 inhibitors
biomarkers
nomogram
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1539514/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1539514/full

Similar Items